Key Considerations for Overcoming the Complexities of Oncology and Cell Therapy Clinical Trials White Paper
Seven key considerations that impact success in oncology and cell therapy clinical trials
Explore seven critical considerations for oncology and cell therapy clinical trials, from patient recruitment and site selection to logistics, data and regulatory requirements, that impact success.
No form required
Seven key considerations for navigating oncology and cell therapy clinical trials
Oncology clinical trials, and cell therapy studies, in particular, bring together complex protocols, evolving standards of care, patient recruitment challenges, specialized site requirements, intricate logistics and demanding regulatory expectations. Successfully managing these interconnected challenges requires an approach that considers the patient experience alongside clinical, operational and scientific requirements.
Sponsors need to consider patient enrollment and burden, evolving trial designs and standards of care, competition for qualified sites, patient identification, operational and manufacturing logistics, extensive data requirements, and regulatory and payor expectations. The white paper explores all seven areas and how experienced clinical research support can help sponsors address them.
Sneak peEk
Seven key considerations shaping oncology and cell therapy studies
Successful oncology and cell therapy trials require sponsors to manage multiple interconnected challenges while keeping patients at the center. This white paper explores seven critical considerations that allow sponsors to best navigate this complexity:
- Patient experience: Reduce participation burden while balancing the demands of complex protocols and assessments.
- Evolving trial designs: Keep pace with changing standards of care, innovative study designs and approaches to dose optimization.
- Site access: Address competition for specialized sites while exploring opportunities to expand qualified research capacity.
- Patient identification and enrollment: Use targeted recruitment, patient support and biomarker strategies to reach appropriate populations.
- Operations and logistics: Coordinate clinical activities, manufacturing and time-sensitive logistics across the cell therapy journey.
- Data requirements: Plan for extensive data collection and safety monitoring throughout development and long-term follow-up.
- Regulatory and payor expectations: Consider evidence requirements early to support regulatory pathways and demonstrate long-term value.
Complex oncology and cell therapy development demands coordination across protocol design, patients, sites, data, manufacturing, logistics and regulatory strategy. Taking a more connected approach and understanding how these elements interact enables sponsors to anticipate risks and make more informed development decisions.
Explore all seven considerations and learn strategies for navigating complex oncology and cell therapy clinical trials
No form required
Related insights
